Vials	Quantity	Discount
Buy 3, Get 5% OFF	3	5%
Buy 5, Get 10% OFF	5	10%
Buy 6+, Get 15% OFF	6 – 9	15%

Vials

Quantity

Discount

Buy 3, Get 5% OFF

Buy 5, Get 10% OFF

10%

Buy 6+, Get 15% OFF

6 – 9

15%

Description:

CJC-1295 (No DAC) 5mg & Ipamorelin 5mg — Dual GH Pathway Research Peptide Formulation

CJC-1295 (no DAC) and Ipamorelin are combined in a synergistic peptide formulation developed for laboratory research examining endogenous growth hormone (GH) signaling. This pairing brings together a GHRH analogue and a growth hormone–releasing peptide (GHRP), enabling investigation of dual-pathway modulation of GH secretion frequency and amplitude in non-clinical models.

Research areas of interest include:

Pituitary GH axis signaling and pulsatile growth hormone release dynamics
Protein synthesis and anabolic signaling research models
Lipid metabolism and lipolysis pathway investigations
Sleep-related endocrine patterns and recovery signaling studies
Connective tissue and muscle regeneration research frameworks

This formulation is frequently utilized as a comprehensive research tool for studying endocrine regulation, performance-recovery mechanisms, and regenerative signaling pathways within controlled laboratory settings.

Intended Use:

For laboratory research use only. Not for human or veterinary use.